长期随访-话题@MedSci

#长期随访#

57篇内容 | 1935人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1967221, encodeId=5050196e22163, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Lancet Neurology：ORATORIO试验的长期随访：早期和持续ocrelizumab治疗对原发性进行性MS的疾病进展具有益处, objectType=article, longId=204334, objectId=30c92043341a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30c92043341a, replyNumber=0, likeNumber=78, createdTime=2021-08-14, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30c92043341a, moduleTitle=Lancet Neurology：ORATORIO试验的长期随访：早期和持续ocrelizumab治疗对原发性进行性MS的疾病进展具有益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30c92043341a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967222, encodeId=0145196e222b6, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！, objectType=article, longId=205645, objectId=b54a2056457f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b54a2056457f, replyNumber=0, likeNumber=80, createdTime=2021-08-29, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b54a2056457f, moduleTitle=Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b54a2056457f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967220, encodeId=783f196e2204f, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=JNNP:强迫症患者丘脑底核的脑深部刺激：一个开放、前瞻性、观察队列的长期随访, objectType=article, longId=202092, objectId=6b1a20209298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b1a20209298, replyNumber=0, likeNumber=72, createdTime=2020-11-15, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b1a20209298, moduleTitle=JNNP:强迫症患者丘脑底核的脑深部刺激：一个开放、前瞻性、观察队列的长期随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b1a20209298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967217, encodeId=ba5f196e21721, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Clinica Chimica Acta：对123名患者进行长期随访评价同型半胱氨酸再甲基化障碍和典型的同型半胱氨酸尿症, objectType=article, longId=197789, objectId=fc4619e789a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc4619e789a8, replyNumber=0, likeNumber=92, createdTime=2020-12-31, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc4619e789a8, moduleTitle=Clinica Chimica Acta：对123名患者进行长期随访评价同型半胱氨酸再甲基化障碍和典型的同型半胱氨酸尿症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc4619e789a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967218, encodeId=886c196e2187b, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=JACC：植入式心律转复除颤器对心衰患者的长期随访结果, objectType=article, longId=198613, objectId=574a1986139e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=574a1986139e, replyNumber=0, likeNumber=107, createdTime=2020-12-28, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=574a1986139e, moduleTitle=JACC：植入式心律转复除颤器对心衰患者的长期随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=574a1986139e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967216, encodeId=5bc5196e21699, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=J Endod：桩核修复牙齿显微根尖外科的长期随访观察, objectType=article, longId=185468, objectId=b22d18546890, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b22d18546890, replyNumber=0, likeNumber=60, createdTime=2020-01-19, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b22d18546890, moduleTitle=J Endod：桩核修复牙齿显微根尖外科的长期随访观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b22d18546890)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967215, encodeId=03a8196e215c6, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=大型人群队列终点事件长期随访技术规范团体标准解读, objectType=article, longId=179963, objectId=84eb1e99634d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84eb1e99634d, replyNumber=0, likeNumber=72, createdTime=2020-04-28, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84eb1e99634d, moduleTitle=大型人群队列终点事件长期随访技术规范团体标准解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84eb1e99634d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967212, encodeId=5b1e196e212f8, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Blood：CLL患者采用依鲁替尼维持治疗的长期随访报告, objectType=article, longId=162829, objectId=57e5162829fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57e5162829fd, replyNumber=0, likeNumber=85, createdTime=2019-11-15, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57e5162829fd, moduleTitle=Blood：CLL患者采用依鲁替尼维持治疗的长期随访报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57e5162829fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967211, encodeId=6558196e211d2, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=基于社区的长期随访研究：青春期躯体症状作为成年期严重精神疾病的预测因子, objectType=article, longId=158180, objectId=07f115818085, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07f115818085, replyNumber=0, likeNumber=62, createdTime=2019-03-23, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07f115818085, moduleTitle=基于社区的长期随访研究：青春期躯体症状作为成年期严重精神疾病的预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07f115818085)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967214, encodeId=3ee2196e21470, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=大型人群队列终点事件长期随访技术规范（T/CPMA 002-2019）, objectType=article, longId=179962, objectId=a7f31e9962f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f31e9962f0, replyNumber=0, likeNumber=67, createdTime=2020-01-08, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f31e9962f0, moduleTitle=大型人群队列终点事件长期随访技术规范（T/CPMA 002-2019）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f31e9962f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967213, encodeId=67b5196e21350, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=NSCLC系列免疫临床研究长期随访OS数据荟萃，深度揭秘免疫“超长待机”, objectType=article, longId=168154, objectId=5bf116815415, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bf116815415, replyNumber=0, likeNumber=69, createdTime=2019-07-25, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bf116815415, moduleTitle=NSCLC系列免疫临床研究长期随访OS数据荟萃，深度揭秘免疫“超长待机”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bf116815415)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967208, encodeId=78ef196e20809, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Graefes Arch Clin Exp Ophthalmol：青光眼患者视网膜神经纤维层裂隙的长期随访结果, objectType=article, longId=142985, objectId=4d0314298584, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d0314298584, replyNumber=0, likeNumber=53, createdTime=2018-10-26, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d0314298584, moduleTitle=Graefes Arch Clin Exp Ophthalmol：青光眼患者视网膜神经纤维层裂隙的长期随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d0314298584)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967205, encodeId=27e8196e205fb, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=JAMA Neurol：30年长期随访研究结果表明1/3的癫痫患者症状未有效控制, objectType=article, longId=124934, objectId=5d6812493426, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d6812493426, replyNumber=0, likeNumber=101, createdTime=2018-01-09, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d6812493426, moduleTitle=JAMA Neurol：30年长期随访研究结果表明1/3的癫痫患者症状未有效控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d6812493426)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967210, encodeId=4f18196e210e0, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=JACC：经皮球囊二尖瓣成形术后的长期随访, objectType=article, longId=150337, objectId=6cc915033eca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cc915033eca, replyNumber=0, likeNumber=65, createdTime=2019-01-24, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cc915033eca, moduleTitle=JACC：经皮球囊二尖瓣成形术后的长期随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cc915033eca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967209, encodeId=0bb5196e20903, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Hepatology：对肝硬化患者的长期随访表明，MELD、年龄和BSA是死亡的主要预测因素, objectType=article, longId=145512, objectId=2b471455128a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b471455128a, replyNumber=0, likeNumber=80, createdTime=2018-10-14, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b471455128a, moduleTitle=Hepatology：对肝硬化患者的长期随访表明，MELD、年龄和BSA是死亡的主要预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b471455128a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967203, encodeId=3da4196e203c7, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Retin Cases Brief Rep：黄斑病-长期随访和病例研究！, objectType=article, longId=121764, objectId=2dc8121e6435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dc8121e6435, replyNumber=0, likeNumber=94, createdTime=2018-06-08, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dc8121e6435, moduleTitle=Retin Cases Brief Rep：黄斑病-长期随访和病例研究！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dc8121e6435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967200, encodeId=f577196e200b3, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=PCYC-1104研究：伊布替尼单药在RR MCL患者中疗效：一项开放性多中心Ⅱ期研究首次研究及长期随访结果, objectType=article, longId=116558, objectId=7fa2116558d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa2116558d1, replyNumber=0, likeNumber=62, createdTime=2018-02-13, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa2116558d1, moduleTitle=PCYC-1104研究：伊布替尼单药在RR MCL患者中疗效：一项开放性多中心Ⅱ期研究首次研究及长期随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fa2116558d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967207, encodeId=d607196e20795, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访, objectType=article, longId=138252, objectId=d2e11382522b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2e11382522b, replyNumber=0, likeNumber=60, createdTime=2018-06-09, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2e11382522b, moduleTitle=Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2e11382522b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967199, encodeId=1936196e199e8, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=伊布替尼单药在RR MCL患者中疗效：一项开放性多中心Ⅱ期研究首次研究及长期随访结果（PCYC-1104研究）, objectType=article, longId=113569, objectId=597e1135690b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597e1135690b, replyNumber=0, likeNumber=37, createdTime=2018-06-16, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597e1135690b, moduleTitle=伊布替尼单药在RR MCL患者中疗效：一项开放性多中心Ⅱ期研究首次研究及长期随访结果（PCYC-1104研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597e1135690b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967202, encodeId=8958196e2028d, content=<a href='/topic/show?id=87729e0451f' target=_blank style='color:#2F92EE;'>#长期随访#</a>, objectTitle=Int J Oral Max Surg：逆时针上下颌骨前移手术和关节盘复位后髁突重塑可以在长期随访中预测吗？, objectType=article, longId=120715, objectId=75af120e159f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75af120e159f, replyNumber=0, likeNumber=87, createdTime=2018-06-02, rootId=0, userName=crystal0562, userId=e4aa106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75af120e159f, moduleTitle=Int J Oral Max Surg：逆时针上下颌骨前移手术和关节盘复位后髁突重塑可以在长期随访中预测吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75af120e159f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

长期随访

2020-05-29

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Lancet Neurology：ORATORIO试验的长期随访：早期和持续ocrelizumab治疗对原发性进行性MS的疾病进展具有益处

2021-08-14

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！

2021-08-29

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

JNNP:强迫症患者丘脑底核的脑深部刺激：一个开放、前瞻性、观察队列的长期随访

2020-11-15

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Clinica Chimica Acta：对123名患者进行长期随访评价同型半胱氨酸再甲基化障碍和典型的同型半胱氨酸尿症

2020-12-31

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

JACC：植入式心律转复除颤器对心衰患者的长期随访结果

2020-12-28

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

J Endod：桩核修复牙齿显微根尖外科的长期随访观察

2020-01-19

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

大型人群队列终点事件长期随访技术规范团体标准解读

2020-04-28

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Blood：CLL患者采用依鲁替尼维持治疗的长期随访报告

2019-11-15

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

基于社区的长期随访研究：青春期躯体症状作为成年期严重精神疾病的预测因子

2019-03-23

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

大型人群队列终点事件长期随访技术规范（T/CPMA 002-2019）

2020-01-08

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

NSCLC系列免疫临床研究长期随访OS数据荟萃，深度揭秘免疫“超长待机”

2019-07-25

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Graefes Arch Clin Exp Ophthalmol：青光眼患者视网膜神经纤维层裂隙的长期随访结果

2018-10-26

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

JAMA Neurol：30年长期随访研究结果表明1/3的癫痫患者症状未有效控制

2018-01-09

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

JACC：经皮球囊二尖瓣成形术后的长期随访

2019-01-24

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Hepatology：对肝硬化患者的长期随访表明，MELD、年龄和BSA是死亡的主要预测因素

2018-10-14

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Retin Cases Brief Rep：黄斑病-长期随访和病例研究！

2018-06-08

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

PCYC-1104研究：伊布替尼单药在RR MCL患者中疗效：一项开放性多中心Ⅱ期研究首次研究及长期随访结果

2018-02-13

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访

2018-06-09

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

伊布替尼单药在RR MCL患者中疗效：一项开放性多中心Ⅱ期研究首次研究及长期随访结果（PCYC-1104研究）

2018-06-16

crystal0562 (审核中...)

前往app查看评论内容

#长期随访#

Int J Oral Max Surg：逆时针上下颌骨前移手术和关节盘复位后髁突重塑可以在长期随访中预测吗？

2018-06-02

科室
- - 订阅+
  - 更多科室
工具
服务